Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology
|
Buy Now
Drug Resistance in Leukemia and Lymphoma III (Hardcover, 3rd 1999 ed.)
Loot Price: R6,099
Discovery Miles 60 990
|
|
Drug Resistance in Leukemia and Lymphoma III (Hardcover, 3rd 1999 ed.)
Series: Advances in Experimental Medicine and Biology, 457
Expected to ship within 10 - 15 working days
|
Cellular drug resistance is a major limitation to the success of
chemotherapy of leu kemia and lymphoma. The importance of this has
now been recognized by both clinicians and scientists. It is of
utmost importance to bridge the gap between laboratory and clinic
in this field of research. This is the main purpose of the series
of International Symposia on Drug Resistance in Leukemia and
Lymphoma. These are held every three years in Am sterdam, The
Netherlands, since 1992. This book contains the proceedings of the
third of these meetings, organised in 1998. The book covers all
important aspects of drug resistance in leukemia and lymphoma, both
in the form of extensive reviews as in manuscripts describing
original data. General mechanisms of resistance are discussed,
including the drug resistance related proteins p glycoprotein, MRP
(multi-drug resistance protein) and LRP (lung resistance protein),
and the role of glutathione and glutathione-S-transferases.
Moreover, more drug type-specific mechanisms of resistance are a
topic, such as for glucocorticoids and antifolates. Much in
formation is provided on apoptosis and its regulators, and on the
results of cell culture drug resistance assays. Several papers
focus on the modulation or circumvention of drug resistance."
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.